選項

倫理決策輔助

{:__('collect %s',倫理決策輔助)}

基於功利主義與義務論框架,為具體商業場景提供道德風險評估與決策建議。

提示內容 複製 複製

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug causes mild but reversible liver damage in long-term users, affecting only 0.5% of patients, with no alternative treatments available. The company must decide whether to immediately recall and suspend sales, which would cause stock price drops and shareholder lawsuits, but might save some patients' health. Please evaluate the moral weight of both recall and non-recall options using both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and non-maleficence) ethical frameworks, and provide a final action recommendation that balances legal compliance, corporate social responsibility, and patient interests, ensuring rigorous logic and adherence to business ethics standards.

複製 複製

請扮演資深企業倫理顧問,針對以下具體商業情境進行道德分析:一家製藥公司發現其已上市藥物在長期服用後存在輕微但可逆的肝臟損傷風險,該風險僅在0.5%的患者中出現,且目前無替代療法。公司面臨是否立即召回並暫停銷售的決策,這將導致股價下跌和股東訴訟,但可能挽救部分患者的健康。請結合功利主義(計算總體福祉最大化)與義務論(尊重患者知情權與不傷害原則)兩種倫理框架,評估召回與不召回兩種方案的道德權重,並給出一個兼顧法律合規、企業社會責任及患者利益的最終行動建議,確保邏輯嚴密且符合商業倫理規範。

複製 複製
評論 (0)
0/300

推薦

倫理決策輔助
Act as a senior corporate ethics consultant to analyze the moral risk of a specific business scenario I provide, which involves resource allocation or conflict of interest. Apply frameworks of utilitarianism and Kantian deontology to identify key stakeholders, assess potential social impact and compliance risks, and offer a balanced recommendation that considers both commercial benefits and social responsibility. Avoid abstract preaching; focus on practical ethical trade-offs in execution, ensuring the output is actionable and aligns with modern corporate governance standards.
倫理決策輔助
Act as a senior corporate ethics consultant and conduct a deep moral deduction for the following specific business scenario: A pharmaceutical company discovers that its flagship drug has mild but irreversible neurological side effects with long-term use. This drug remains the only effective treatment for a rare severe disease, and the company faces immense financial pressure to maintain its stock price to complete a merger. Please combine the utilitarian principle of the greatest happiness for the greatest number with the deontological principles of respecting patient autonomy and non-maleficence to analyze the ethical weights of continuing sales, voluntary recall, or reducing prices while disclosing information. Avoid simple binary judgments; instead, construct a comprehensive evaluation model including stakeholder impact, long-term reputational risk, and social trust costs, ultimately providing a balanced recommendation that balances business sustainability with moral responsibility.
倫理決策輔助
Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its existing basic drug has minor but non-fatal side effects, and fixing it requires huge costs that could lead to price hikes. Please evaluate whether to proactively recall and disclose information by combining the impact on stakeholders from utilitarianism with the responsibility of honest disclosure from deontology, and finally provide an action recommendation that balances business survival and moral responsibility.
倫理決策輔助
Act as a corporate ethics consultant to conduct a moral risk assessment for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, but the cost of recall would bankrupt the company and affect thousands of employees. Combine consequentialist utilitarianism with deontological duty ethics to analyze whether to voluntarily disclose and recall, considering the impact on stakeholders, and finally provide a specific action recommendation that balances moral responsibility and corporate survival, avoiding abstract preaching and focusing on an executable ethical decision path.
倫理決策輔助
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, yet stopping the medication carries higher risks. Please evaluate whether to proactively disclose these side effects and adjust usage guidelines by integrating the philosophical frameworks of utilitarianism (maximizing overall well-being) and deontology (respecting patient autonomy and informed consent). Avoid simple binary judgments; instead, deeply explore the complex impacts of disclosure on patient trust, corporate legal liability, and public health, ultimately providing an action plan that balances legal compliance with moral responsibility, ensuring the language is natural and fluent without using structured lists or AI clichés.
倫理決策輔助
Act as a senior corporate ethics consultant to provide decision-making advice for the following specific business scenario: A pharmaceutical company discovers that its existing basic drug has rare but severe side effects. Recalling it would cause the company to go bankrupt and affect accessibility for millions of patients, while not recalling it might harm some patients' health. Please combine utilitarian consequence assessment with deontological responsibility principles to analyze the conflict of interests among stakeholders, and provide a balanced solution that considers both moral responsibility and survival reality. Avoid absolute moral judgments, but instead offer specific action paths based on risk minimization and enhanced transparency.
OR